Form 4 for CAH Cardinal Health
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-07 · accession 0000721371-23-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-08 | 2023-08-07 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | A - Grant | $0.00 | +12.8K | 39.7K | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-08-07 | A | A | 12,760 | $0.00 | 39,681 | D | — | — |